Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the page history.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision v3.4.3 has been added and revision v3.4.2 has been removed from the history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study history shows an added site revision entry (v3.4.2) and the removal of an older funding/operating status notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check67 days agoChange DetectedThe page adds a site-wide funding notice and records a new revision (v3.4.1) with a Study Status entry, while removing the prior revision (v3.4.0).SummaryDifference0.7%

- Check74 days agoChange DetectedUI changes on the Study Record History page introduce a glossary, color-coded highlights (green for additions, red for deletions), and the revision label Revision: v3.4.0, while removing the No FEAR Act data note and the older Revision: v3.3.4 label.SummaryDifference0.6%

- Check88 days agoChange DetectedThe page history shows a new revision v3.3.4 has been added and the previous revision v3.3.3 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.